MedTrace Logo

Nationwide Uniform Scientific Evaluation of Flexible and Integrated Treatment Projects From 2022 Onwards

NCT05855720 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2024-08-07

No results posted yet for this study

Summary

This study is an evaluation of flexible and integrated psychiatric care models (according to § 64b of the German Social Code Book V (SGB V)) (FIT) including new FIT projects starting after 2022 and the prolongation of any of 19 already established FIT projects (mainly at German psychiatric hospitals). The central concern of this evaluation is to answer the question whether FIT care offers advantages over standard care. The orientation of model care is a more cross-sectoral provision of services through more flexible psychiatric treatment intensities. However, FIT program structures depend on the individual situation and organization of the FIT hospital together with the participating statutory health insurance (SHI) funds.

Conditions

  • Mental Health
  • Cross-sectoral Treatment
  • Flexible and Integrated Treatment
  • FIT
  • Psychiatry
  • Evaluation Study
  • Cohort Studies

Interventions

OTHER

FIT model project

Several statutory health insurance (SHI) funds have established contracts with hospitals for an alternative remuneration / financing of patients treated in the hospital (FIT hospital). Some of those contracts already started in 2013 and were prolonged. Some FIT contracts will start freshly (until June 2026). These contracts encourage FIT hospitals to test alternative treatment options for their patients (insured with the involved SHI funds), for example fewer inpatient and more outpatient treatment.

Sponsors & Collaborators

  • Institute of Social Medicine and Health Services Research, Medical Faculty, Otto-von-Guericke- University Magdeburg, Germany

    collaborator UNKNOWN

  • WIG2 Scientific Institute for Health Economics and Health System Research Leipzig, Germany

    collaborator UNKNOWN

  • Technische Universität Dresden

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2038-12-31
Completion
2041-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855720 on ClinicalTrials.gov